Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
10x Genomics Inc (TXG)
NASDAQ:TXG
Holding TXG?
Track your performance easily
See the Price Targets and Ratings of:
TXG Analyst Ratings
Moderate Buy
6 Buy
6 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
TXG Stock 12 Month Forecast
Average Price Target
$26.55
▲(17.06% Upside)
| Highest Price Target$46.00 | Average Price Target$26.55 | Lowest Price Target$16.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Leerink Partners
Initiated
09/04/24
Canaccord Genuity
Reiterated
09/03/24
Morgan Stanley
Assigned
08/13/24
TD Cowen
Assigned
08/09/24
Bank of America Securities
Assigned
08/09/24
Deutsche Bank
Reiterated
08/09/24
Barclays
Reiterated
08/09/24
Stifel Nicolaus
Reiterated
08/09/24
Jefferies
Upgraded
07/22/24
J.P. Morgan
Downgraded
07/18/24
Goldman Sachs
$26→$16
Sell
-29.45%
Downside
Reiterated
07/08/24
10X Genomics (TXG) PT Lowered to $16 at Goldman SachsGoldman Sachs analyst Matthew Sykes lowered the price target on 10X Genomics (NASDAQ: TXG) to $16.00 (from $26.00) while maintaining a Sell rating.
Wolfe Research
―
Hold
―
Downgraded
06/27/24
10x Genomics (TXG) Receives a New Rating from a Top Analyst
Guggenheim
―
Hold
―
Downgraded
06/25/24
10x Genomics downgraded to Neutral from Buy at Guggenheim10x Genomics downgraded to Neutral from Buy at Guggenheim
UBS
$52→$30
Hold
32.28%
Upside
Reiterated
05/01/24
10X Genomics (TXG) PT Lowered to $30 at UBSUBS analyst John Sourbeer lowered the price target on 10X Genomics (NASDAQ: TXG) to $30.00 (from $52.00) while maintaining a Neutral rating.
Citi
$60
Buy
164.55%
Upside
Reiterated
02/15/24
Maintaining Buy Rating on 10x Genomics Amidst Strong Xenium Sales and Promising Future Product Launches
Best Analysts Covering 10x Genomics
Which Analyst Should I Follow If I Want to Buy TXG and Sell After:
1 Month
xxx
Success Rate
8/15 ratings generated profit
Average Return
+1.06%
reiterated a xxx
rating 9 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 53.33% of your transactions generating a profit, with an average return of +1.06% per trade.
3 Months
xxx
Success Rate
8/15 ratings generated profit
Average Return
-0.16%
reiterated a xxx
rating 9 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 53.33% of your transactions generating a profit, with an average return of -0.16% per trade.
1 Year
Success Rate
7/13 ratings generated profit
Average Return
-4.53%
assigned a buy rating 3 months ago
Copying Tejas Savant's trades and holding each position for 1 Year would result in 53.85% of your transactions generating a profit, with an average return of -4.53% per trade.
2 Years
xxx
Success Rate
4/15 ratings generated profit
Average Return
-10.52%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 26.67% of your transactions generating a profit, with an average return of -10.52% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
TXG Analyst Recommendation Trends
Rating
May 24
Jun 24
Jul 24
Aug 24
Sep 24
Strong Buy
4
4
3
3
4
Buy
4
4
5
5
5
Hold
3
6
10
10
7
Sell
1
1
2
1
1
Strong Sell
0
0
0
0
0
total
12
15
20
19
17
Each month's total comprises the sum of three months' worth of ratings.
TXG Financial Forecast
TXG Stock Forecast FAQ
What is TXG’s average 12-month price target, according to analysts?
Based on analyst ratings, 10x Genomics Inc’s 12-month average price target is $26.55.
What is TXG’s upside potential, based on the analysts’ average price target?
10x Genomics Inc has 17.06% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TXG a Buy, Sell or Hold?
10x Genomics Inc has a consensus rating of Moderate Buy which is based on 6 buy ratings, 6 hold ratings and 1 sell ratings.
What is 10x Genomics Inc’s price target?
The average price target for 10x Genomics Inc is $26.55. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $46.00 ,the lowest forecast is $16.00. The average price target represents 17.06% Increase from the current price of $22.68.
The highest analyst price target is $46.00 ,the lowest forecast is $16.00. The average price target represents 17.06% Increase from the current price of $22.68.
What do analysts say about 10x Genomics Inc?
10x Genomics Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of TXG?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.